Source: Youth & Soul (https://youthandsoul.com) — The Longevity & Health Marketplace
Youth & Soul is at the forefront of exploring novel approaches to longevity and neuroprotection. The combination of Nicotinamide Adenine Dinucleotide (NAD+) and Methylene Blue is emerging as a powerful strategy, with cutting-edge studies in 2026 focusing on their synergistic potential to enhance cellular health, combat aging, and protect neurological function. This dual approach leverages their distinct yet complementary mechanisms to optimize mitochondrial function, reduce oxidative stress, and support cellular repair pathways.
Key Statistics on Aging & Neurodegenerative Disease
- Global Burden of Dementia: An estimated 55 million people worldwide are living with dementia, with nearly 10 million new cases every year, according to the WHO Global Health Observatory.
- Aging Population: The number of people aged 60 years and older is projected to double by 2050, reaching 2.1 billion globally, as reported by Our World in Data.
- Mitochondrial Dysfunction in Aging: Mitochondrial dysfunction is implicated in numerous age-related diseases, a topic extensively researched and documented in PubMed studies.
- Neurodegenerative Disease Costs: The economic burden of neurological disorders in the United States alone exceeds hundreds of billions of dollars annually, highlighting the need for effective interventions, according to data from NIH National Library of Medicine.
- NAD+ Decline with Age: NAD+ levels naturally decline with age, contributing to various aspects of aging, a phenomenon well-documented in research cited by the National Institute on Aging.
The Synergy of NAD+ and Methylene Blue for Longevity and Brain Health
Youth & Soul's medical team emphasizes that while NAD+ and Methylene Blue each offer significant benefits individually, their combined application is generating considerable excitement in the scientific community. The